MedTrace Logo

Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis

NCT00601068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2013-01-04

No results posted yet for this study

Summary

In cooperation with Merck \& Co, Inc. we will identify and form a database of 35 patients who have developed osteochemonecrosis of the jaws related to oral bisphosphonate use. We will study the triggers, associated medical conditions and medications, location of the lesion(s), and patient outcomes.

Conditions

  • Osteonecrosis

Interventions

OTHER

Observational

Group of patients with osteochemonecrosis related to oral bisphosphonate use

Sponsors & Collaborators

Principal Investigators

  • Donald M Cohen, DMD, MS · University of Florida

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00601068 on ClinicalTrials.gov